You were told there was nothing wrong on your whole-body PET-CT, and then a few days later a breast ultrasound shows a lump and someone starts talking about a biopsy. Honestly, your mind just goes blank. "Wait, the expensive whole-body scan said I was clear, so what is this now?" When this happens while a family member is in the middle of treatment for another cancer, the shock hits twice as hard. But this isn't a case of one test being wrong. It happens because the two scans look at the body in fundamentally different ways.
PET-CT, to put it simply, is a scan that sweeps the entire body at once. After injecting a substance similar to glucose, it picks out the areas that pull in an unusually large amount of it, in other words places where metabolism is very active. It's strong at giving you the big picture of where distant spread might be hiding. The trade-off is that small lumps, or ones with slow metabolism, tend to slip through the net. Dense tissue like the breast, and lesions smaller than 1 cm, fall right into PET-CT's blind spot. If your doctor trailed off with something like "PET-CT is whole-body, so...", that pause was a roundabout way of pointing to exactly this limitation.
Breast ultrasound, by contrast, focuses on the breast alone. It looks in considerable detail at the shape of a small lump, whether its borders are smooth or jagged, and even whether blood flow inside it has increased. So when ultrasound catches a small lump that PET-CT missed, the two scans aren't contradicting each other. If anything, it's the result of each doing what it does best. It helps to think of it as using a telescope that surveys the whole body alongside a magnifying glass that zooms in on one area.
So does "blood flow has increased, let's do a biopsy" mean it's cancer? Not necessarily. Blood flow inside a lump is common even in benign lumps, and even when imaging alone rates the probability of cancer as low, doctors often still recommend a biopsy. Imaging only tells you a probability; the true identity becomes certain only when cells are taken out directly and examined under a microscope. Even if the likelihood is only around 10 percent, when leaving that 10 percent unchecked is judged to be riskier, the idea is to clear your mind with one test. More often than not it isn't meant to scare you, but rather to put you at ease.
If you ask which of the two is more accurate, the honest answer is that it depends on what you're looking for. PET-CT is more trustworthy for confirming distant spread in broad terms, while ultrasound and biopsy are more reliable for assessing the nature of a small lump inside the breast. So rather than doubting one or the other, it's much easier on the mind to accept that the picture is only complete when you read both results together. The same goes for a thyroid nodule or lymph node finding that shows up alongside. These aren't things to draw conclusions about right now, but part of a process of checking one thing at a time, in order.
When you're at the side of a family member going through treatment, it's only natural for your heart to sink every time another test is added. Try not to blame yourself too much or paint the worst-case scenario in advance. Jot down your questions and ask the attending medical team directly at the next appointment. This article is only meant to help you understand why the scans seem to show different things; the diagnosis and direction of treatment should, in the end, follow the judgment of the medical team that actually examined the patient.